The most interesting observation we saw was in CML patient samples, where inhibition of Sirt1 resulted in a return of BMAL1 oscillation which was previously absent in patient samples (Figure 4). Here, BMAL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.